Biosynthetic Production covers Methylated Tryptamine Derivatives including DMT and 5-MeO-DMT OXFORD, Ohio and DENVER, Aug. 11, 2022 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB), (OTCQB: PSYBF) (“PsyBio” or the “Company“), an intellectual property driven biotechnology company focused upon discovery and development of novel, psycho-targeted therapeutics to potentially improve mental and…


Previous articlePsychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed CMO Turns Activist Shareholder; California Decrim. Bill Tentatively Clears Hurdle
Next articleField Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing